David Sidransky
Director, TAMIR BIOTECHNOLOGY, INC.
Companies
- ASCENTAGE PHARMA GROUP INTERNATIONALBoard member Mar 19, 2026 to now1
- Galmed Pharmaceuticals Ltd.Board member Mar 18, 2026 to now2
- Champions OncologyBoard member Feb 23, 2010 to now3
- Orgenesis Inc.Board member Oct 25, 2018 to Dec 21, 20234
- Old Ayala, IncBoard member May 7, 2020 to Jan 23, 20235
- AdvaxisBoard member Sep 19, 2013 to Jan 23, 20236
- Cactus Acquisition Corp. 1 LtdBoard member Nov 4, 2021 to Nov 4, 20217
- Akari Therapeutics PlcBoard member Jan 2, 2015 to Jan 2, 20158
- Champions OncologyChair Sep 1, 2009 to Sep 1, 20099
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Champions Oncology CSBR767,043 shares10$3.6M at $4.63Oct 12, 2022- ASCENTAGE PHARMA GROUP INTERNATIONAL AAPG10,641 shares11$164.4K at $15.45Mar 23, 2026
- Galmed Pharmaceuticals Ltd. EOCN12,500 shares12$35.1K at $2.81Mar 18, 2026
Advaxis ADXS139 shares13Jan 23, 2023- Old Ayala, Inc0 shares14Jan 19, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 19, 2023Granted 46 shares of Advaxis13
- Jan 19, 2023Returned to company 250 shares of Old Ayala, Inc14
- Oct 12, 2022Shares withheld for tax 3,562 shares at $7.51 of Champions Oncology10
- Oct 12, 2022Exercised options 8,333 shares at $3.21 of Champions Oncology10
- Oct 15, 2021Shares withheld for tax 2,629 shares at $10.08 of Champions Oncology15
- Oct 15, 2021Exercised options 16,667 shares at $1.59 of Champions Oncology15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARChampions Oncology, Board member
- 4SEC EDGAROrgenesis Inc., Board member
- 5SEC EDGAROld Ayala, Inc, Board member
- 6SEC EDGARAdvaxis, Board member
- 7
- 8SEC EDGARAkari Therapeutics Plc, Board member
- 9SEC EDGARChampions Oncology, Chair
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARForm 4 filed Oct 19, 2021